ABBV Stock-Based Compensation
AbbVie · Stock-Based Compensation
ABBV Stock-Based Compensation
Latest reported$976.00Mperiod ending
ABBV TTM Stock-Based Comp ($162.98M → $976.00M)
TTM stock-based compensation
High-resolution chart · PNG
ABBV stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 976,000,000 | |
| 989,000,000 | |
| 955,000,000 | |
| 962,000,000 | |
| 934,000,000 | |
| 973,000,000 | |
| 911,000,000 | |
| 872,000,000 | |
| 821,000,000 | |
| 782,000,000 | |
| 747,000,000 | |
| 754,000,000 | |
| 750,000,000 | |
| 678,000,000 | |
| 671,000,000 | |
| 668,000,000 | |
| 677,000,000 | |
| 729,000,000 | |
| 692,000,000 | |
| 699,000,000 | |
| 726,000,000 | |
| 803,000,000 | |
| 753,000,000 | |
| 696,000,000 | |
| 609,000,000 | |
| 460,000,000 | |
| 430,000,000 | |
| 421,000,000 | |
| 421,000,000 | |
| 419,000,000 | |
| 421,000,000 | |
| 428,000,000 | |
| 424,000,000 | |
| 415,000,000 | |
| 365,000,000 | |
| 363,000,000 | |
| 361,000,000 | |
| 356,000,000 | |
| 353,000,000 | |
| 331,000,000 | |
| 317,000,000 | |
| 301,000,000 | |
| 282,000,000 | |
| 272,000,000 | |
| 261,000,000 | |
| 254,000,000 | |
| 241,000,000 | |
| 235,000,000 | |
| 233,000,000 | |
| 231,000,000 | |
| 212,000,000 | |
| 206,459,000 | |
| 193,911,000 | |
| 182,995,000 | |
| 187,000,000 | |
| 195,990,000 | |
| 190,486,000 | |
| 179,560,000 | |
| 162,976,000 |